Zhejiang CONBA Pharmaceutical Co Ltd (600572) - Total Liabilities

Latest as of March 2026: CN¥2.85 Billion CNY ≈ $417.57 Million USD

Based on the latest financial reports, Zhejiang CONBA Pharmaceutical Co Ltd (600572) has total liabilities worth CN¥2.85 Billion CNY (≈ $417.57 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Zhejiang CONBA Pharmaceutical Co Ltd - Total Liabilities Trend (2001–2025)

This chart illustrates how Zhejiang CONBA Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Zhejiang CONBA Pharmaceutical Co Ltd (600572) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Zhejiang CONBA Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Zhejiang CONBA Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Zhejiang Dayuan Pumps Ind Co SHG:603757	China	CN¥698.45 Million
Borregaard ASA OL:BRG	Norway	Nkr3.79 Billion
Concentrix Corporation NASDAQ:CNXC	USA	$7.89 Billion
Atalaya Mining Ltd F:E5S1	Germany	€199.83 Million
Paradeep Phosphates Limited NSE:PARADEEP	India	Rs111.53 Billion
Shenzhen Kingdom SCI Tech Co Ltd SHG:600446	China	CN¥1.66 Billion
Harmonic Inc NASDAQ:HLIT	USA	$350.15 Million
Peker Gayrimenkul Yatirim Ortakligi AS IS:PEKGY	Turkey	TL3.30 Billion

Liability Composition Analysis (2001–2025)

This chart breaks down Zhejiang CONBA Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang CONBA Pharmaceutical Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.98	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.39	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang CONBA Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang CONBA Pharmaceutical Co Ltd (2001–2025)

The table below shows the annual total liabilities of Zhejiang CONBA Pharmaceutical Co Ltd from 2001 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥2.83 Billion ≈ $414.44 Million	-5.25%
2024-12-31	CN¥2.99 Billion ≈ $437.40 Million	-23.13%
2023-12-31	CN¥3.89 Billion ≈ $569.02 Million	+7.84%
2022-12-31	CN¥3.61 Billion ≈ $527.66 Million	+6.04%
2021-12-31	CN¥3.40 Billion ≈ $497.61 Million	-13.45%
2020-12-31	CN¥3.93 Billion ≈ $574.96 Million	-20.10%
2019-12-31	CN¥4.92 Billion ≈ $719.60 Million	-0.06%
2018-12-31	CN¥4.92 Billion ≈ $720.07 Million	+37.59%
2017-12-31	CN¥3.58 Billion ≈ $523.36 Million	-10.74%
2016-12-31	CN¥4.01 Billion ≈ $586.35 Million	-19.92%
2015-12-31	CN¥5.00 Billion ≈ $732.16 Million	+70.85%
2014-12-31	CN¥2.93 Billion ≈ $428.55 Million	+57.26%
2013-12-31	CN¥1.86 Billion ≈ $272.52 Million	-11.23%
2012-12-31	CN¥2.10 Billion ≈ $307.01 Million	+55.60%
2011-12-31	CN¥1.35 Billion ≈ $197.30 Million	+80.42%
2010-12-31	CN¥747.34 Million ≈ $109.36 Million	-4.28%
2009-12-31	CN¥780.76 Million ≈ $114.25 Million	+20.19%
2008-12-31	CN¥649.60 Million ≈ $95.06 Million	-6.31%
2007-12-31	CN¥693.32 Million ≈ $101.45 Million	+10.37%
2006-12-31	CN¥628.20 Million ≈ $91.93 Million	+12.07%
2005-12-31	CN¥560.55 Million ≈ $82.03 Million	+34.63%
2004-12-31	CN¥416.37 Million ≈ $60.93 Million	+21.67%
2003-12-31	CN¥342.22 Million ≈ $50.08 Million	+30.68%
2002-12-31	CN¥261.88 Million ≈ $38.32 Million	-1.45%
2001-12-31	CN¥265.74 Million ≈ $38.89 Million	--

About Zhejiang CONBA Pharmaceutical Co Ltd

SHG:600572 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.53 Billion

CN¥10.45 Billion CNY

Market Cap Rank

#7296 Global

#1676 in China

Share Price

CN¥4.12

Change (1 day)

+0.24%

52-Week Range

CN¥4.06 - CN¥4.94

All Time High

CN¥10.42